Would you have Flat Affect when you have Bipolar Disorder?

Summary

Flat affect is found among people with Bipolar disorder, especially for people who are female, 40-49 old, take medication Zyprexa and have Depression. We study 70 people who have Flat affect and Bipolar disorder from FDA and social media. Find out below who they are, other conditions they have and drugs they take.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Bipolar Disorder

Bipolar disorder (mood disorder) can be treated by Lamictal, Lithium carbonate, Seroquel, Abilify, Lamotrigine (latest reports from 60,196 Bipolar disorder patients)

Flat Affect

Flat affect (absence of emotional response to a situation) (latest reports from 1,769 Flat affect patients).

On Sep, 15, 2016

70 people who have Bipolar Disorder and Flat Affect are studied.


Number of reports submitted per year:

Would you have Flat affect when you have Bipolar disorder?

Gender of people who have Bipolar Disorder and experience Flat Affect *:

  • female: 61.76 %
  • male: 38.24 %

Age of people who have Bipolar Disorder and experience Flat Affect *:

  • 0-1: 0.0 %
  • 2-9: 1.54 %
  • 10-19: 9.23 %
  • 20-29: 12.31 %
  • 30-39: 10.77 %
  • 40-49: 32.31 %
  • 50-59: 26.15 %
  • 60+: 7.69 %

Severity if Bipolar Disorder and experience Flat Affect *:

  • least: 0.0 %
  • moderate: 0.0 %
  • severe: 100 %
  • most severe: 0.0 %

Top co-existing conditions for these people *:

  • Depression (10 people, 14.29%)
  • Hallucination (8 people, 11.43%)
  • Anxiety (4 people, 5.71%)
  • Thinking Abnormal (3 people, 4.29%)
  • Nightmare (3 people, 4.29%)
  • Muscle Disorder (3 people, 4.29%)
  • Back Pain (3 people, 4.29%)
  • Antidepressant Therapy (3 people, 4.29%)
  • Acne (3 people, 4.29%)
  • Post-Traumatic Stress Disorder (2 people, 2.86%)

Most common drugs for these people *:

  • Zyprexa (19 people, 27.14%)
  • Geodon (17 people, 24.29%)
  • Lithium Carbonate (13 people, 18.57%)
  • Seroquel (11 people, 15.71%)
  • Depakote (11 people, 15.71%)
  • Risperdal (10 people, 14.29%)
  • Cogentin (10 people, 14.29%)
  • Celexa (10 people, 14.29%)
  • Lamotrigine (9 people, 12.86%)
  • Lamictal (7 people, 10.00%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Flat affect and Bipolar disorder?

Browse all symptoms of Bipolar disorder

a b c d e f g h i j k l m n o p q r s t u v w x y z

Could your drugs cause Flat affect

Flat affect

Other conditions that could case Flat affect

Flat affect

Related studies

Can you answer these questions?

More questions for: Bipolar disorder, Flat affect

You may be interested in these reviews

More reviews for: Bipolar disorder, Flat affect


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.